Fisiopatologia Metabòlica
2014 SGR 168
![Foto de Fisiopatologia Metabòlica](/img/grupo.png)
![Foto de Hospital Universitari de Bellvitge](/img/noimage_org.png)
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (87)
2024
-
Glycogen accumulation modulates life span in a mouse model of amyotrophic lateral sclerosis
Journal of Neurochemistry, Vol. 168, Núm. 5, pp. 744-759
2023
-
Antibodies against the flotillin-1/2 complex in patients with multiple sclerosis
Brain Communications, Vol. 5, Núm. 2
-
Lipidomic Alterations in the Cerebral Cortex and White Matter in Sporadic Alzheimer’s Disease
Aging and Disease, Vol. 14, Núm. 5, pp. 1887-1916
-
Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study
Journal of Clinical Medicine, Vol. 12, Núm. 23
-
Sphingolipid desaturase DEGS1 is essential for mitochondria-associated membrane integrity
The Journal of clinical investigation, Vol. 133, Núm. 10
-
XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (I)
Revista de neurologia, Vol. 77, Núm. 1, pp. 19-30
-
XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (II)
Revista de neurologia, Vol. 77, Núm. 2, pp. 47-60
2022
-
A motor neuron disease mouse model reveals a non-canonical profile of senescence biomarkers
Disease models & mechanisms, Vol. 15, Núm. 8
-
Activating cannabinoid receptor 2 preserves axonal health through GSK-3β/NRF2 axis in adrenoleukodystrophy
Acta Neuropathologica, Vol. 144, Núm. 2, pp. 241-258
-
Delayed cognitive processing and treatment status quo bias in early-stage multiple sclerosis
Multiple Sclerosis and Related Disorders, Vol. 68
-
Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology
Multiple Sclerosis and Related Disorders, Vol. 63
-
Measuring productivity loss in early relapsing-remitting multiple sclerosis
Multiple Sclerosis and Related Disorders, Vol. 58
-
Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer
Cancers, Vol. 14, Núm. 12
2021
-
Acute ischemic stroke triggers a cellular senescence-associated secretory phenotype
Scientific Reports, Vol. 11, Núm. 1
-
Cell stress induces mislocalization of transcription factors with mitochondrial enrichment
International Journal of Molecular Sciences, Vol. 22, Núm. 16
-
Direct costs of relapses in patients with relapsing-remitting multiple sclerosis
Neurology Perspectives, Vol. 1, Núm. 3, pp. 160-169
-
Dysregulated protein phosphorylation: A determining condition in the continuum of brain aging and Alzheimer's disease
Brain Pathology, Vol. 31, Núm. 6
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Identification of patients with relapsing multiple sclerosis eligible for high-efficacy therapies
Neurodegenerative Disease Management, Vol. 11, Núm. 3, pp. 251-261
-
Lipid alterations in human frontal cortex in ALS-FTLD-TDP43 proteinopathy spectrum are partly related to peroxisome impairment
Neuropathology and Applied Neurobiology, Vol. 47, Núm. 4, pp. 544-563